Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 3:33 pm Sale |
2022-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
LYTTON LAURENCE W | 0 0.000% |
-43,474 (Position Closed) |
Filing History |
| 2023-02-13 3:24 pm Sale |
2022-12-31 | 13G | Apollo Endosurgery, Inc. APEN |
LYTTON LAURENCE W | 3,403,180 6.700% |
-286,740 (-7.77%) |
Filing History |
| 2023-02-13 3:14 pm Purchase |
2022-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 482,430 4.990% |
64,651 (+15.47%) |
Filing History |
| 2023-02-13 2:55 pm Sale |
2022-12-31 | 13G | Catalyst Biosciences, Inc. CBIO |
LYTTON LAURENCE W | 177,822 7.100% |
-294,793 (-62.37%) |
Filing History |
| 2023-02-10 7:02 pm Purchase |
2022-12-31 | 13G | EMCORE Corporation EMKR |
LYTTON LAURENCE W | 292,327 7.800% |
87,937 (+43.02%) |
Filing History |
| 2023-01-19 6:34 pm Purchase |
2023-01-10 | 13G | BIOLASE, Inc. BIOL |
LYTTON LAURENCE W | 24,611 9.990% |
24,611 (New Position) |
Filing History |
| 2022-11-23 2:40 pm Purchase |
2022-11-14 | 13G | Exagen Inc. XGN |
LYTTON LAURENCE W | 833,305 5.100% |
833,305 (New Position) |
Filing History |
| 2022-11-23 1:01 pm Purchase |
2022-11-18 | 13G | TFF Pharmaceuticals, Inc. TFFP |
LYTTON LAURENCE W | 125,506 8.800% |
125,506 (New Position) |
Filing History |
| 2022-05-20 6:45 pm Purchase |
2022-05-11 | 13G | EMCORE Corporation EMKR |
LYTTON LAURENCE W | 204,390 5.400% |
139,112 (+213.10%) |
Filing History |
| 2022-05-18 4:47 pm Purchase |
2022-05-09 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
LYTTON LAURENCE W | 3,210,552 5.900% |
3,210,552 (New Position) |
Filing History |
| 2022-03-30 12:48 pm Purchase |
2022-03-02 | 13G | Scientific Industries, Inc. SCND |
LYTTON LAURENCE W | 408,229 5.700% |
408,229 (New Position) |
Filing History |
| 2022-03-04 5:23 pm Purchase |
2022-02-22 | 13G | Catalyst Biosciences, Inc. CBIO |
LYTTON LAURENCE W | 472,615 5.900% |
442,952 (+1493.26%) |
Filing History |
| 2022-02-15 4:57 pm Purchase |
2021-12-31 | 13G | Apollo Endosurgery, Inc. APEN |
LYTTON LAURENCE W | 3,689,920 9.300% |
1,041,770 (+39.34%) |
Filing History |
| 2022-02-15 2:25 pm Sale |
2021-12-31 | 13G | DiaMedica Therapeutics Inc. DMAC |
LYTTON LAURENCE W | 1,071,970 4.100% |
-308,296 (-22.34%) |
Filing History |
| 2022-02-15 2:18 pm Sale |
2021-12-31 | 13G | VERTEX ENERGY INC VTNRQ |
LYTTON LAURENCE W | 3,649,067 5.700% |
-444,494 (-10.86%) |
Filing History |
| 2022-02-15 2:16 pm Purchase |
2021-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
LYTTON LAURENCE W | 43,474 6.800% |
3,107 (+7.70%) |
Filing History |
| 2022-02-15 1:50 pm Sale |
2021-12-31 | 13G | Ra Medical Systems, Inc. RMED |
LYTTON LAURENCE W | 4,400 0.800% |
-419 (-8.70%) |
Filing History |
| 2022-02-15 1:49 pm Sale |
2021-12-31 | 13G | EMCORE Corporation EMKR |
LYTTON LAURENCE W | 65,279 1.800% |
-106,552 (-62.01%) |
Filing History |
| 2022-02-15 1:48 pm Purchase |
2021-12-31 | 13G | Viracta Therapeutics, Inc. VIRX |
LYTTON LAURENCE W | 255,876 0.700% |
255,876 (New Position) |
Filing History |
| 2022-02-15 1:09 pm Sale |
2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
LYTTON LAURENCE W | 85,416 2.500% |
-81,604 (-48.86%) |
Filing History |